Stage IIIA Rectal Cancer AJCC v7 Recruiting Phase 1 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0092025 (Stage IIIA Rectal Cancer AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03300544Talimogene Laherparepvec, Capecitabine, and Chemoradiation Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal CancerTreatment